AYTU BIOPHARMA, INC — All Filings
890 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
10QSB/A
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEL AM
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000935836-26-000109 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001535264-26-000010 | Feb 13, 2026 | — |
| 10-Q | FORM 10-Q | 0001437749-26-002804 | Feb 3, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001437749-26-002799 | Feb 3, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-001543 | Jan 20, 2026 | — |
| 8-K | FORM 8-K | 0001437749-25-037389 | Dec 10, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000682 | Nov 14, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-034825 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-034822 | Nov 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001193805-25-001566 | Nov 12, 2025 | — |
| ARS | ARS | 0001437749-25-031722 | Oct 24, 2025 | Jun 30, 2025 |
| DEFA14A | FORM DEFA14A | 0001437749-25-031720 | Oct 24, 2025 | — |
| DEF 14A | FORM DEF 14A | 0001437749-25-031719 | Oct 24, 2025 | Dec 10, 2025 |
| 5 | — | 0000912282-25-001096 | Oct 20, 2025 | Jun 30, 2025 |
| 4 | FORM 4 | 0001437749-25-030650 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030648 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030645 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030642 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030639 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030636 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030634 | Oct 7, 2025 | Oct 3, 2025 |
| 4 | FORM 4 | 0001437749-25-030632 | Oct 7, 2025 | Oct 3, 2025 |
| S-8 | FORM S-8 | 0001437749-25-029726 | Sep 23, 2025 | — |
| 10-K | FORM 10-K | 0001437749-25-029723 | Sep 23, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-029721 | Sep 23, 2025 | — |
| SCHEDULE 13G | — | 0001535264-25-000049 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000496 | Aug 13, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-025441 | Aug 7, 2025 | Aug 5, 2025 |
| SCHEDULE 13G | — | 0000921895-25-001849 | Jun 26, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-001848 | Jun 26, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-001845 | Jun 26, 2025 | — |
| SCHEDULE 13G | — | 0000921895-25-001844 | Jun 26, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-020973 | Jun 23, 2025 | Jun 20, 2025 |
| 8-K | FORM 8-K | 0001437749-25-020579 | Jun 17, 2025 | — |
| SCHEDULE 13G | — | 0000935836-25-000423 | Jun 13, 2025 | — |
| 4 | FORM 4 | 0001437749-25-019958 | Jun 10, 2025 | Jun 9, 2025 |
| 4 | FORM 4 | 0001437749-25-019956 | Jun 10, 2025 | Jun 9, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057852 | Jun 9, 2025 | Jun 6, 2025 |
| SCHEDULE 13D/A | — | 0001104659-25-057855 | Jun 9, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-019868 | Jun 9, 2025 | — |
| 424B4 | FORM 424B4 | 0001437749-25-019761 | Jun 9, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-019719 | Jun 6, 2025 | Jun 5, 2025 |
| 8-K | FORM 8-K | 0001437749-25-019718 | Jun 6, 2025 | Jun 5, 2025 |
| S-1MEF | FORM S-1MEF | 0001437749-25-019599 | Jun 6, 2025 | — |
| EFFECT | — | 9999999995-25-001849 | Jun 5, 2025 | — |
| S-1/A | FORM S-1/A | 0001437749-25-019550 | Jun 5, 2025 | — |
| CORRESP | — | 0001437749-25-019197 | Jun 2, 2025 | — |
| CORRESP | — | 0001437749-25-019196 | Jun 2, 2025 | — |
| S-1 | FORM S-1 | 0001437749-25-019189 | Jun 2, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-017989 | May 21, 2025 | — |